X-135985492-CG-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4BS1BS2
This summary comes from the ClinGen Evidence Repository: The allele frequency of the c.-5del variant in SLC9A6 (NM_006359.2) is 0.02% in European (non-Finnish) sub population in gnomAD v2, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4). The c.-5del variant is observed in the hemizygous state in at least 2 unaffected individuals (internal database - GeneDx) (BS2). In sumarry, the c.-5del variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BS1, BP4, BS2). LINK:https://erepo.genome.network/evrepo/ui/classification/CA16621203/MONDO:0010278/033
Frequency
Consequence
ENST00000370695.8 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC9A6 | NM_001379110.1 | c.-57+21del | intron_variant | ENST00000630721.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC9A6 | ENST00000630721.3 | c.-57+21del | intron_variant | 4 | NM_001379110.1 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111033Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33371
GnomAD3 exomes AF: 0.0000809 AC: 3AN: 37084Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 4844
GnomAD4 exome AF: 0.0000228 AC: 22AN: 963389Hom.: 0 Cov.: 27 AF XY: 0.0000268 AC XY: 8AN XY: 298327
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111033Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33371
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 04, 2022 | Variant summary: SLC9A6 c.-5delG is located in the untranslated mRNA region upstream of the initiation codon (in transcript NM_006359.3). This variant doesn't alter the consensus Kozak sequence, which plays a role in the recognition of the AUG (START) codon. In addition, this variant is located to intron 1 in other alternative transcripts (e.g. in NM_001177651.2 and NM_001379110.1), and results in a change that can be described as: c.-57+21delG, therefore could affect splicing: 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8.1e-05 in 37084 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-5delG in individuals affected with Christianson Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and likely benign. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 04, 2020 | - - |
Christianson syndrome Benign:1
Benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Feb 23, 2024 | The allele frequency of the c.-5del variant in SLC9A6 (NM_006359.2) is 0.02% in European (non-Finnish) sub population in gnomAD v2, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4). The c.-5del variant is observed in the hemizygous state in at least 2 unaffected individuals (internal database - GeneDx) (BS2). In sumarry, the c.-5del variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BS1, BP4, BS2). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at